002393 力生製藥
按盤價 
21.790 -1.060 (-4.639%)
21.790 -1.060 (-4.639%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 7.613 | 3.815 | 7.821 | 2.137 | 2.803 |
| 總資產報酬率 ROA (%) | 6.334 | 3.191 | 6.536 | 1.786 | 2.391 |
| 投入資產回報率 ROIC (%) | 7.164 | 3.593 | 7.403 | 2.025 | 2.651 | 邊際利潤分析 |
| 銷售毛利率 (%) | 57.820 | 55.068 | 59.398 | 57.589 | 58.379 |
| 營業利潤率 (%) | 44.278 | 16.589 | 36.409 | 10.297 | 12.538 |
| 息稅前利潤/營業總收入 (%) | 38.382 | 12.899 | 31.270 | 4.449 | 4.579 |
| 淨利潤/營業總收入 (%) | 37.158 | 13.918 | 31.381 | 8.164 | 11.182 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 31.463 | 57.713 | 43.668 | 124.283 | 94.316 |
| 價值變動淨收益/利潤總額(%) | 74.349 | 47.733 | 3.837 | 20.244 | 14.037 |
| 營業外收支淨額/利潤總額(%) | -2.999 | -2.640 | 0.097 | 0.253 | 0.155 | 償債能力分析 |
| 流動比率 (X) | 4.622 | 4.099 | 4.501 | 3.597 | 4.265 |
| 速動比率 (X) | 4.314 | 3.798 | 4.219 | 3.324 | 3.851 |
| 資產負債率 (%) | 15.501 | 17.035 | 15.174 | 17.797 | 15.034 |
| 帶息債務/全部投入資本 (%) | 0.892 | 1.716 | 0.425 | 0.834 | 0.175 |
| 股東權益/帶息債務 (%) | 10,603.537 | 5,455.405 | 22,287.935 | 11,341.693 | 54,114.921 |
| 股東權益/負債合計 (%) | 541.436 | 483.992 | 559.003 | 461.884 | 565.143 |
| 利息保障倍數 (X) | -8.333 | -3.954 | -6.044 | -0.757 | -0.574 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 62.464 | 34.041 | 25.410 | 41.029 | 46.233 |
| 存貨周轉天數 (天) | 137.935 | 120.123 | 144.350 | 158.398 | 184.941 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 20/03/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
